Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...
Oracle Corporation (NYSE: ORCL) has received notice of an unsolicited mini-tender offer by TRC Capital Investment Corporation (TRC) dated March 24, 2026, to purchase up to 1,000,000 shares of Oracle's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results